Filter
2611
Filtered Results: 2611
Text search:
The
National
Institute
for
Communicable
Diseases
Featured
Recommendations
225
New Publications
685
Language
Document type
No document type
1389
Studies & Reports
523
Guidelines
324
Manuals
161
Strategic & Response Plan
101
Training Material
45
Fact sheets
31
Situation Updates
21
Resource Platforms
9
Infographics
4
Brochures
3
Countries / Regions
Global
157
India
133
Kenya
87
South Africa
87
Ethiopia
70
Western and Central Europe
66
Liberia
57
Latin America and the Carribbean
56
Uganda
50
Bangladesh
48
Nepal
46
Sierra Leone
45
Africa
44
Nigeria
42
Ghana
39
Rwanda
39
Philippines
32
Malawi
32
Namibia
27
Myanmar / Burma
27
Zambia
26
Tanzania
24
Mozambique
24
Congo, Democratic Republic of
22
Syria
21
Cambodia
21
South–East Asia Region
21
Indonesia
20
East and Southern Africa
20
Asia
19
Eastern Europe
19
Ukraine
17
West and Central Africa
16
Guinea
15
Brazil
15
Lesotho
15
Pakistan
14
Germany
13
Eastern Europe and Central Asia
11
Senegal
10
Zimbabwe
10
Botswana
10
Western Pacific Region
10
Burkina Faso
8
South Sudan
8
Afghanistan
8
Thailand
8
Middle East and North Africa
8
Haiti
7
Colombia
7
Yemen
7
USA
6
Moldova
6
Vietnam
6
Somalia
5
Jordan
5
China
5
Peru
5
Eswatini/ Swaziland
5
Venezuela
5
Russia
5
Mali
4
Cameroon
4
Iraq
4
Lebanon
4
Papua New Guinea
4
Sudan
4
Argentina
4
Angola
4
Sri Lanka
4
Chile
4
Iran
4
Turkmenistan
4
United Kingdom
4
Spain
4
Côte d’Ivoire / Ivory Coast
3
Turkey
3
North Macedonia
3
Bolivia
3
Paraguay
3
Albania
3
Laos
3
Tajikistan
3
North America
3
Japan
3
Mauritius
3
Portugal
3
Saudi Arabia
2
Egypt
2
Gambia
2
Benin
2
Central African Republic
2
Serbia
2
El Salvador
2
Greece
2
Palestine
2
Southern Africa
2
Timor Leste/ East Timor
2
Guinea-Bissau
1
Morocco
1
Niger
1
Togo
1
Malaysia
1
Mauritania
1
Hungary
1
Croatia
1
Ecuador
1
Libya
1
Mexico
1
Fiji
1
Bhutan
1
Poland
1
Italy
1
Djibouti
1
Armenia
1
Canada
1
Qatar
1
Bulgaria
1
Estonia
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Jamaica
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Azerbaijan
1
Belarus
1
Israel
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
1031
Public Health
288
Clinical Guidelines
201
Key Resources
95
Women & Child Health
82
Capacity Building
37
Pharmacy & Technologies
30
Toolboxes
COVID-19
208
Mental Health
175
NCDs
154
TB
143
HIV
132
Planetary Health
128
Rapid Response
107
AMR
90
Disability
80
Global Health Education
74
Caregiver
71
Ebola
70
NTDs
61
Conflict
39
Refugee
33
Pharmacy
30
Natural Hazards
27
Health Financing Toolbox
24
Specific Hazards
18
Polio
16
Zika
15
Cholera
9
Social Ethics
9
South Sudan
1
The aim of the pandemic preparedness checklist is primarily to provide an outline of the essential minimum elements of preparedness, as well as ele...
Asthma is the most common noncommunicable disease in children, and among the most common in adults. According to ... most recent estimates from the Global Asthma Network Phase I study, around one in 10 children and adults have symptoms of asthma and one in 20 school-aged children have severe asthma symptoms, with marked variations in prevalence and in prevalence trends between countries and regions of the world. The Global Burden of Disease Study estimated that asthma caused the loss of 21.6 million healthy years of life (disability-adjusted life years) and 461 069 deaths in 2019. Approximately 90% of the asthma burden of disease is borne by people living low and middle income countries (LMICs). Some countries report very high (up to 90%) rates of uncontrolled asthma. While the prevalence of asthma is highest in countries with a high Socio-Demographic Index (SDI), death rates from asthma are highest in countries with low and lower middle incomes.
School health programmes have been demonstrated to be the most cost-effective way to influence health behaviours in young people. The purpose of this two-part handbook is to support sch...
The increasing global trend of Antimicrobial resistance (AMR) has gradually emerged as a major public health challenge for the entire world. AMR ha...
Countries who have no testing capacity and national COVID-19 laboratories with limited experience on COVID-19 virus testing are encouraged to send the first five positives and ... first ten negative COVID-19 samples to WHO reference laboratories providing confirmatory testing for COVID-19.
Updates 29 April 2020
The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for<...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detecti...
The 2021 COVID-19 Strategic Preparedness and Response Plan (SPRP) for AFR serves as a regional guide for a holistic public health response to COVID...
Reliable cause specic mortality statistics are the cornerstone of national health information
systems. They are essential for evidence-based de...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable ... (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the...
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
Patel V, Chisholm D, Dua T, et al., editors.
Washington (DC): The International Bank ... Reconstruction and Development / The World Bank; 2016 Mar 14.
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease...
The current trend in AMR in Uganda and globally is rising and calls for immediate action. The 71st UN General Assembly (UNGA), ... 68th World Health Assembly, and organizations including the World Health Organization (WHO), the Food and Agriculture Organization (FAO), and the World Organization for Animal Health (OIE), have agreed on a set of actions that member countries such as Uganda are committed to implement. The Government of Uganda (GoU) has put in place a framework through this National AMR Action Plan to address the threat AMR poses to the welfare of the peoples of Uganda. The Action Plan sets out a coordinated and collaborative One Health approach involving key stakeholders in government and other sectors to confront the threat and shall be coordinated by a Uganda National Antimicrobial Resistance Committee (UNAMRC).
SADC Communicable Disease Project
Component 5: Scaling-up Child and Adolescent HIV, TB and Malaria Continuum of Care and Support
DRAFT POST REGIONAL CONSENSUS AND VALIDATION MEETING Oct 2012
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific con...
The document summarizes the infrastructure and activities for Ebola virus disease (EVD) prepared...
The health of the people and health services are in crisis, and together as partners this plan commits us to strategies aimed at achieving our goal of:
Strengthened primary health care ... all, and improved service delivery for the rural majority and the urban disadvantaged.
Original file: 67 MB
Strengthened primary health care ... all, and improved service delivery for the rural majority and the urban disadvantaged.
Original file: 67 MB
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central A...
